Quick Facts

• Support for High Blood Pressure: Nipidol is used to help manage hypertension, a long-term condition characterized by elevated blood pressure.
• Management of Angina: It is indicated for the treatment of chronic stable angina (chest discomfort) and Prinzmetal's or variant angina.

---

Nipidol is a medication prescribed to support the management of certain cardiovascular conditions. Its primary use is in the treatment of hypertension, or high blood pressure, where it is utilized to facilitate the maintenance of blood pressure within a target range. This therapeutic support may lessen the likelihood of more severe cardiovascular events.

The medication is also indicated for the management of angina, which involves heart-related chest discomfort. Specifically, it is used to address chronic stable angina and vasospastic angina (Prinzmetal’s or variant angina). In this context, Nipidol is believed to influence the blood flow to the heart muscle, a process that can contribute to the reduction of symptoms. For certain patients, Nipidol may be used alone or in combination with other therapeutic agents as part of an overall care regimen.

Nipidol is recognized for its use to assist in the control of blood pressure, either as a single therapy or adjunctively. Careful monitoring by a healthcare professional is necessary to support optimal results in individual patient care.

Who Can and Cannot Use Nipidol?

The population eligibility rules for Nipidol (Amlodipine) are strictly defined by government regulatory agencies based on contraindications, age, and pre-existing medical conditions.

---

Absolute Contraindications (Must Not Use)

Nipidol is contraindicated in individuals with:

• Known hypersensitivity to amlodipine or other dihydropyridine calcium channel blockers.
• Severe hypotension.
• Shock, including cardiogenic shock.
• Obstruction of the outflow tract of the left ventricle (e.g., high grade aortic stenosis).
• Hemodynamically unstable heart failure following acute myocardial infarction.

---

Eligibility by Age and Condition

Population Group	Regulatory Status
Adults (18+ years)	Approved for hypertension and angina.
Children (6–17 years)	Approved for hypertension only.
Children (Under 6 years)	Safety and effectiveness not established.
Severe Hepatic Impairment	Use with caution and slow titration; lowest initial dose is advised.
Renal Impairment	May be used at normal doses.

---

Pregnancy and Lactation

Use during pregnancy is generally recommended only when there is no safer alternative for managing the condition. Amlodipine is excreted in human milk, requiring a regulatory assessment regarding continuation of breastfeeding or the medicine.

Nipidol’s official interaction profile is defined by pharmacokinetic and pharmacodynamic considerations documented by regulatory authorities. The most significant constraint involves the drug Simvastatin. Co-administration of Nipidol increases the systemic exposure of Simvastatin by approximately 77%, requiring a regulatory instruction to limit the maximum dose of Simvastatin to 20 mg daily.

Pharmacokinetic interactions also occur with agents that modify the CYP3A4 metabolic pathway. Strong or moderate CYP3A4 inhibitors (such as certain antifungals or antibiotics) may increase the systemic exposure of Nipidol itself due to reduced clearance, necessitating monitoring. Conversely, CYP3A4 inducers (including certain herbal products) may cause Nipidol plasma concentration to vary. Nipidol may also increase the exposure of Cyclosporine and Tacrolimus, requiring frequent monitoring of their blood levels.

Pharmacodynamic effects are observed with alcohol and other antihypertensive agents, which may result in an additive blood pressure lowering effect. Additionally, Nonsteroidal Anti-inflammatory Drugs (NSAIDs) may cause a reduction in the drug's antihypertensive action. Certain substances like grapefruit or grapefruit juice can increase Nipidol concentration. Finally, individuals with hepatic impairment experience a significant 40% to 60% increase in Nipidol systemic exposure due to decreased clearance, a population-specific alteration noted in official prescribing information.

Nipidol is a non-selective beta-adrenergic receptor antagonist and an alpha1-adrenergic receptor antagonist. It acts as a competitive inhibitor at both receptor types in the cardiovascular system.

At beta1-adrenergic receptors, primarily located in the cardiac tissue, Nipidol blocks the binding of endogenous catecholamines (e.g., norepinephrine, epinephrine). This antagonism leads to a reduction in the adenylyl cyclase activity, which decreases the intracellular concentration of cyclic AMP (cAMP). The resulting reduction in cAMP/PKA signaling modulates calcium handling in cardiomyocytes, specifically reducing the L-type Ca^2+ channel opening and sarcoplasmic reticulum calcium release. The intracellular consequence is a reduction in cardiac contractility (negative inotropy) and a decrease in heart rate (negative chronotropy).

Concurrently, Nipidol blocks alpha1-adrenergic receptors present on the vascular smooth muscle cell membranes. This antagonism inhibits the Gq protein-coupled pathway that typically mediates vasoconstriction. The downstream cascade of reduced IP3 and diacylglycerol formation limits the mobilization of intracellular calcium, promoting smooth muscle relaxation and leading to vasodilation.

The combined systemic-level physiological consequences are a decrease in cardiac output and a reduction in peripheral vascular resistance, leading to a modulation of systemic arterial pressure.

How to Use Nipidol

Nipidol is administered orally, typically as a single-ingredient tablet, available in strengths of 2.5 mg, 5 mg, and 10 mg. Adherence to a once-daily schedule is the standard approach for this medicine. The tablet can be taken with or without food, providing flexibility for daily administration.

---

Official Administration Rules

Instruction Principle	Details
Standard Adult Dose	Treatment usually initiates at 5 mg once daily. The typical maintenance dose ranges from 5 mg to 10 mg, with 10 mg established as the maximum daily intake.
Dose Titration	Any adjustment to the dose is a measured process. A period of 7 to 14 days should generally pass between dose increases to ensure the drug reaches a steady concentration within the body.
Specific Populations	Lower initial doses are specified for certain groups. Older adults and individuals with hepatic insufficiency are advised to begin with 2.5 mg once daily. For pediatric patients aged 6 to 17 years requiring treatment for hypertension, the effective dose range is limited to 2.5 mg to 5 mg once daily.

---

Usage Protocol

The structural usage protocol focuses on sustained, long-term administration. The daily oral route simplifies the overall regimen for prolonged use. The strict requirement for a 7-to-14 day interval between dose changes establishes a procedural safeguard, ensuring that adjustments are systematic and guided by a full assessment of the previous dosage level. This defined structure of official dosing ranges and fixed adjustment intervals defines how the medicine is applied in standard clinical practice.

Research Evidence / Overview of Studies for Nipidol

---

Research Evidence for High Blood Pressure (Hypertension)

Research examining Nipidol in adults with high blood pressure, or hypertension, has primarily involved large-scale Randomized Controlled Trials (RCTs). These trials are controlled clinical studies that compare Nipidol to an inactive substance (placebo) or to other classes of blood pressure medications. Extensive Systematic Reviews and Meta-analyses have also been conducted.

These studies monitored specific outcomes related to systemic imbalance. Researchers measured the change in blood pressure levels (systolic and diastolic) over the study period. Additionally, many large trials observed the patterns related to the recorded occurrence rates of Major Cardiovascular Events (MACE) such as stroke and heart attack over observation periods lasting several years.

While studies monitored blood pressure changes, the interpretation of results in comparative studies may be complex, as observed differences may relate to the specific blood pressure levels achieved rather than the drug class itself. Data for certain groups, such as children, remain insufficient for long-term cardiovascular outcomes.

---

Research Evidence for Chronic Stable Angina

For the study of chronic stable chest discomfort (angina), research has explored short-term, controlled clinical trials. These studies were designed to evaluate Nipidol in patients experiencing exercise-induced symptoms.

In these trials, researchers primarily measured outcomes related to physical discomfort and functional measures. Studies monitored changes in total exercise time and the time until the onset of chest discomfort during stress tests. Research describes changes measured during the study period, contributing to the broader evidence landscape regarding symptom patterns.

The follow-up durations for many of the core efficacy studies focusing on symptom management were limited. Evidence providing direct insight into the long-term impact on major cardiovascular events, specifically in patients with isolated stable angina symptoms, remains limited compared to the data for hypertension outcomes.

---

What is Still Uncertain About Nipidol Research

While a significant volume of research exists, data remain insufficient or uncertain in specific areas. Data for certain patient groups, particularly pediatric populations, remain insufficient to fully establish the long-term effects on cardiovascular outcomes.

Subgroup findings are uncertain in some comparative studies, where the observed differences between treatments may not be solely attributed to the drug class. Results apply only to the populations studied. Comparative evidence is lacking regarding long-term hard cardiovascular outcomes specifically in isolated stable angina populations.

Key Studies & References

1. Amlodipine Use in Pediatric Hypertension
2. Amlodipine: Uses, Side Effects & Dosage (Clinical Overview)

Common questions about Nipidol (FAQ)

---

Q: What should I do if I miss a dose of Nipidol?

Regulatory documents state that if a dose is missed, patients should take it as soon as they remember. However, if it is almost time for the next dose, the missed dose should be skipped to maintain the schedule. Official instructions specify that doses should not be doubled, and it is generally advised not to take the medicine if more than 12 hours have passed since the missed dose time.

---

Q: Does Nipidol cure high blood pressure?

Nipidol is classified as an agent for the long-term management or treatment of high blood pressure (hypertension) and angina. It helps to control these chronic conditions by regulating blood flow and cardiac workload, but its regulatory role is the management of these chronic cardiovascular conditions.

---

Q: Can children take Nipidol? If so, at what ages and for what condition?

According to official product information, Nipidol is approved for the treatment of hypertension only in pediatric patients aged 6 to 17 years. Safety and effectiveness in children younger than 6 years of age have not been established by regulatory authorities.

---

Q: How do I know if Nipidol is working to control my blood pressure?

Effectiveness is typically assessed by monitoring changes in a patient's blood pressure levels over time. Official regulatory guidelines emphasize the need for regular monitoring of blood pressure, heart rate, and sometimes kidney function during the course of treatment to assess the drug's effect.

---

Q: What are the most common side effects of Nipidol?

The most common adverse reaction reported in clinical studies is edema (swelling), particularly of the ankles or feet, which can be dose-related. Other frequently reported side effects include fatigue, nausea, abdominal discomfort, and somnolence (sleepiness).

---

Q: How long does it take for Nipidol to start working after I take the first tablet?

The medicine is generally designed for sustained action. The drug reaches its highest concentration in the bloodstream between 6 and 12 hours after taking a single oral dose. Consistent, steady-state blood levels are usually achieved after taking the medicine daily for 7 to 8 days.

---

Q: What should I do with my unused or expired Nipidol?

Official disposal guidelines suggest using a drug take-back program or an authorized collection site as the preferred method. If a take-back program is unavailable, official guidelines recommend mixing the product with an undesirable substance (such as dirt or coffee grounds), sealing it in a container, and then discarding it in the household trash.

---

Q: Does Nipidol cause weight gain?

In clinical studies, both weight increase and weight decrease have been reported as side effects. These occurrences are classified as uncommon, based on official prescribing information (occurring in less than 1% of patients).

---

Q: Can Nipidol be cut or crushed?

Official labeling states that Nipidol tablets should be swallowed whole with a glass of water. Official product information contains no regulatory recommendations to cut or crush the tablets.

Official Storage and Disposal Instructions for Nipidol

The required storage conditions for Nipidol tablets are strictly defined by regulatory documents to maintain product stability and integrity.

Storage Requirements

Condition	Requirement
Temperature	Store at controlled room temperature, specifically 20 C to 25 C (68 F to 77 F).
Protection	Keep in the original container, tightly closed, and protected from light and moisture.
Safety	The medication must be kept out of the sight and reach of children.

Disposal Requirements

Disposal of unused or expired Nipidol must follow official regulatory guidelines. The preferred method is to use a drug take-back program or an authorized collection site. If a take-back program is unavailable, the product must be mixed with an undesirable substance (such as used coffee grounds or dirt) and placed in a sealed container before discarding in the household trash. It is strictly prohibited to flush Nipidol down the toilet or pour it into a sink.